{
  "docId": "019de514-833c-7520-a4a9-200b68fbb681",
  "docSlug": "d869e39fe11534a9d64784c9e4f475f2",
  "documentTitle": "Bausch+Lomb | Results Presentation Deck | 47 slides",
  "authorId": "bausch-lomb",
  "authorName": "Bausch + Lomb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 28,
  "pageCount": 47,
  "prevPage": 27,
  "nextPage": 29,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de514-833c-7520-a4a9-200b68fbb681/28",
  "deckHref": "/decks/019de514-833c-7520-a4a9-200b68fbb681",
  "deckJsonHref": "/decks/019de514-833c-7520-a4a9-200b68fbb681.json",
  "deckAnchorHref": "/decks/019de514-833c-7520-a4a9-200b68fbb681#slide-28",
  "components": [
    {
      "bbox": {
        "h": 0.01,
        "w": 0.379,
        "x": 0.15,
        "y": 0.945
      },
      "kind": "source-note",
      "text": "1. See slide 1 for further information on forward-looking statements.",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c9b6c7d6-920c-413e-b9e4-c744f52b7f2d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.74,
        "w": 0.875,
        "x": 0.045,
        "y": 0.148
      },
      "kind": "table",
      "text": "Surgical Product Status Upcoming Milestone enVista Envy™ Canadian study completed enrollment in 1Q22; Expect Canadian launch 2023; enVista® Trifocal IOL (Intraocular Lens) U.S. study completed enrollment in 2Q22 Expect US and EU launch 2024 StableVisc™ Cohesive OVD Clinical Study Report completed 2Q22; FDA submission filed early 3Q22 Expect US approval 4Q22 enVista Aspire™ US and Canada submission planned for 4Q22 enVista® Extended Range Monofocal IOL EU submission planned for 2Q23 Expect US and Canada launch 2H23 enVista Dynamic™ enVista® Extended Depth of Focus IOL Clinical study to begin 3Q23 Expect 2025/2026 launch Lux Premium IOL Launched in Europe Continued expansion of platform expected in 2023 Next Generation Surgical Platform - System 202x Alpha prototype build and test underway Beta prototyping expected 1Q23 eyeTELLIGENCE® Digital Platform Beta software release at AAO October 2022; Software as Medical Device (SaMD) documentation ongoing US commercial release expected 1Q23 3D Microscope Approval expected 2023 Launch expected in 2023 Teneo™ Excimer Laser Enrollment completed for myopia study Enrolled first patient 3Q22 in hyperopia study Expected myopia launch in U.S. in 2023",
      "attrs": {},
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "706f6e7b-c8cf-44f1-afa6-65fd3456de8d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.42,
        "x": 0.045,
        "y": 0.08
      },
      "kind": "title",
      "text": "Pipeline and Upcoming Milestones¹",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "63306085-e4c0-4a6d-864c-32a7f473247f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}